High Mark Wealth Management LLC Xenon Pharmaceuticals Inc. Transaction History
High Mark Wealth Management LLC
- $173 Million
- Q4 2024
A detailed history of High Mark Wealth Management LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 6,100 shares of XENE stock, worth $218,319. This represents 0.14% of its overall portfolio holdings.
Number of Shares
6,100
Previous 5,000
22.0%
Holding current value
$218,319
Previous $196,000
21.94%
% of portfolio
0.14%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
70.4MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$203 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$162 Million1.73% of portfolio
-
Wellington Management Group LLP Boston, MA3.78MShares$135 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$104 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$103 Million0.06% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.23B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...